Michał Karbownik

Dr. Michał Karbownik

Department of Pharmacology and Toxicology, Medical University of Lodz, 90-752 Lodz, Poland
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Pharmacological Reports
Verified
Journal Article
Closed access
Michał KarbownikMichał Karbownik
Michał Karbownik
JNJerzy Z. Nowak
Jerzy Z. Nowak

23 February 2016 in FEMS Microbiology Letters
Verified
Journal Article
Closed access
PDF file
Michał KarbownikMichał Karbownik
Michał Karbownik
AWAnna Wiktorowska-Owczarek
Anna Wiktorowska-Owczarek
EKEdward Kowalczyk
Edward Kowalczyk
PKPaulina Kwarta
Paulina Kwarta
ŁMŁukasz Mokros
Łukasz Mokros
TPTadeusz Pietras
Tadeusz Pietras
The effectiveness of an educational board game developed to teach the pharmacology of antimicrobial drugs to medical students was compared with the lecture-based seminar as a supplemental tool to improve short- and long-term knowledge retention and the perception of the learning method by students. A group of 124 students was randomized to board game and control groups. Short-term knowledge retention was assessed by comparing differences in post- and pre-tests scores, and long-term knowledge retention by comparing final examination scores. Both didactic methods seem to improve short-term knowledge retention to similar extent. Long-term knowledge retention of board game seminar participants was higher than those who attended the lecture-based seminar (ANCOVA, P = 0.035). The effect was most pronounced within 14 days after the intervention (ANOVA, P = 0.007). The board game was well perceived by the students. The board game seems to be a promising didactic tool, however, it should be further tested to assess its full educational utility.

9 June 2022 in Frontiers in Psychiatry
Verified
Journal Article
Open access
MDMaria Dobielska
Maria Dobielska
NBNatalia Karina Bartosik
Natalia Karina Bartosik
KZKamil A. Zyzik
Kamil A. Zyzik
EKEdward Kowalczyk
Edward Kowalczyk
Michał KarbownikMichał Karbownik
Michał Karbownik
Depression is the major cause of disability globally. Apart from lowered mood and accompanying symptoms, it leads to cognitive impairment that altogether predicts disadvantaged social functioning. Reduced cognitive function in depression appears a bit neglected in the field of clinical and molecular psychiatry, while it is estimated to occur in two-thirds of depressed patients and persist in at least one third of remitted patients. This problem, therefore, requires elucidation at the biomolecular and system levels and calls for improvement in therapeutic approach. In this review study, we address the above-mentioned issues by discussing putative mechanisms of cognitive decline in depression: (1) increased oxidative stress and (2) inflammation, (3) disturbed hypothalamus-pituitary-adrenals axis, and (4) reduced monoamines functionality. Moreover, we acknowledge additional underpinnings of cognitive impairment in depressed elderly: (5) vascular-originated brain ischemia and (6) amyloid-beta plaque accumulation. Additionally, by reviewing molecular, pre-clinical and clinical evidence, we propose gut microbiota-targeted strategies as potential adjuvant therapeutics. The study provides a consolidated source of knowledge regarding mechanisms of cognitive impairment in depression and may path the way toward improved treatment options.

24 June 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Michał KarbownikMichał Karbownik
Michał Karbownik
EPEwelina Paul
Ewelina Paul
MNMaja Nowicka
Maja Nowicka
ZNZuzanna Nowicka
Zuzanna Nowicka
RKRadosław Przemysław Kowalczyk
Radosław Przemysław Kowalczyk
TPTadeusz Pietras
Tadeusz Pietras
Despite offering little overall benefit and emerging concerns about their safety, dietary supplements have become increasingly popular. Trust in advertising them may contribute to high confidence in dietary supplements in public opinion. To develop and validate a screening questionnaire intended for the general public regarding knowledge about dietary supplements and a questionnaire on trust in advertising dietary supplements, and to identify the association between these constructs. The development and validation of the measures was overseen by the panels of experts. The conceptual frameworks of the constructs were scientifically well grounded. A set of semi-structured interviews and anonymous web-based surveys was performed. The final questionnaire was applied to 220 non-medically educated people and 121 medically educated people. A 17-item questionnaire on knowledge about dietary supplements and eight-item questionnaire on trust in advertising dietary supplements were developed. The measures presented satisfactory proof of validity, however, the psychometric properties of the questionnaire on knowledge were modest. Both the knowledge about dietary supplements in the study group and trust in advertising them were low. A significant negative relationship was found between knowledge about dietary supplements and trust in advertising them among the general public (Pearson’s r = -0.42, 95%CI: -0.52 to -0.30, p<0.0001). This association was especially pronounced in people who reported not taking dietary supplements (Pearson’s r = -0.61, 95%CI: -0.76 to -0.39, p<0.0001). The extensive advertising of dietary supplements appears to be in conflict with promoting evidence-based knowledge about them, which raises substantial concerns for the public health. The results of the study are only preliminary and require further confirmation and exploration.

6 February 2018 in Cancer Biomarkers
Verified
Journal Article
Closed access
PDF file
WSWeronika Switlik
Weronika Switlik
Michał KarbownikMichał Karbownik
Michał Karbownik
MSMichał Suwalski
Michał Suwalski
JKJózef Kozak
Józef Kozak
JSJanusz Szemraj
Janusz Szemraj
BACKGROUND: Although an immense effort has been made to develop novel diagnostic methods and treatment strategies for non-small cell lung cancer (NSCLC), the survival rate of this disease has remained virtually unchanged. Small non-coding RNAs called

13 April 2016 in Cancer Biomarkers
Verified
Journal Article
Open access
PDF file
MCMagdalena Cybula
Magdalena Cybula
ȽWȽukasz Wieteska
Ƚukasz Wieteska
MJMagdalena Józefowicz-Korczyńska
Magdalena Józefowicz-Korczyńska
Michał KarbownikMichał Karbownik
Michał Karbownik
WGWeronika Lucas Grzelczyk
Weronika Lucas Grzelczyk
JSJanusz Szemraj
Janusz Szemraj
BACKGROUND: Although the development of novel diagnostic and treatment strategies concerning laryngeal cancer is highly intensive, the survival rate remains virtually unchanged. Small non-coding RNAs appear to be very promising biomarkers - and so re